Categories: News

Efor strengthens its presence in Asia with the acquisition of No deviation

LYON, France, March 3, 2026 /PRNewswire/ — Efor, a global leader specializing in quality and compliance for the Life Sciences industry, announces the acquisition of Singapore-based No deviation, a company recognized for its expertise in Commissioning, Qualification & Validation (CQV), Computer System Validation (CSV), Quality Compliance and Digital Enablement.

- Advertisement -

Founded in 2013, Efor has built a leading international platform dedicated to quality and compliance for Life Sciences industries. With more than 3,000 professionals operating across 18 countries, the group supports global pharmaceutical, biotechnology and medical device leaders.

- Advertisement -

This operation represents a significant milestone in Efor’s continued expansion across Asia. With more than 300 professionals now operating in the region, Efor reaches a new level of scale and strengthens its position within the Asian market.

- Advertisement -

Founded in 2007, No deviation operates today in Singapore, China and Ireland, with Singapore serving as its primary hub.

- Advertisement -

With an established presence across key Asian Life Sciences markets, No deviation has developed strong local execution capabilities, particularly in fast-growing biopharmaceutical environments.

- Advertisement -

The alliance builds on a shared vision of delivering high-value quality and compliance solutions across complex industrial projects.

- Advertisement -

By bringing No deviation into the group, Efor significantly strengthens its regional capabilities in Commissioning, Qualification & Validation (CQV) and high-standard complianceservices.

- Advertisement -

This acquisition further reinforces Efor’s global expansion strategy, combining sustained organic growth with targeted acquisitions.

- Advertisement -

“Asia is a strategic pillar of our global vision. With No deviation, we are strengthening our presence and positioning Efor as a leading quality and compliance playeracross key Asian markets,” said Mathieu Roger, Founder and President of Efor.

- Advertisement -

“Joining Efor opens a new chapter for No Deviation. This partnership expands our reach while preserving the technical depth and entrepreneurial spirit that define our organization,” said Pierre Winnepenninckx, Founder of No deviation.

- Advertisement -

Logo – https://mma.prnewswire.com/media/2922502/Efor_Logo.jpg

- Advertisement -

Contact : Floriane CARRET – floriane.carret@efor-group.com

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/efor-strengthens-its-presence-in-asia-with-the-acquisition-of-no-deviation-302699944.html

- Advertisement -

Recent Posts

MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026

Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe…

7 hours ago

Boston Dental Named The Best Dentist in Boston

Prestigious Recognition Highlights Boston Dental's Commitment to Excellence in Dental and Aesthetic Services June 19,…

7 hours ago

Comprehensive Healthcare opens Columbia Valley Center for Recovery, the Tri-Cities’ first inpatient behavioral health treatment and recovery facility

YAKIMA, Wash., June 19, 2026 (GLOBE NEWSWIRE) -- Comprehensive Healthcare today announced that the Columbia…

7 hours ago

TheDoseReport Announces Which GLP-1 is Best? Semaglutide and Tirzepatide

NEW YORK, June 21, 2026 (GLOBE NEWSWIRE) -- TheDoseReport.com Releases Analysis: Which GLP-1 is Best?…

15 hours ago

From Living Rooms to Garages: GARVEE Expands Affordable Cooling Solutions for Summer 2026

ONTARIO, Calif., June 21, 2026 (GLOBE NEWSWIRE) -- GARVEE launches the 2026 Summer AC Campaign…

15 hours ago

Crypto News: AlphaPepe Expands Listings With BiFinance CEX Deal as Bitcoin Price Prediction Eyes $250,000

MONACO, June 20, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after the…

15 hours ago